Cidara治療 CDTX 深 滬
已收盤 09-20 16:00:00 美东时间
11.27
-0.450
-3.84%
華盛通- 最 高11.88
- 今 開11.70
- 成交量 4.03万股
- 最 低 10.94
- 昨 收 11.72
- 總市值 5141.15万
- 52周最高 24.40
- 市盈率 靜 --
- 換手率 0.88%
- 52周最低 10.004
- 委 比 -67.16%
- 總股本 456.18万
- 歷史最高 382.60
- 量 比 1.93
- 振 幅 8.02%
- 歷史最低 8.00
- 每 手 1
- 風險率 2.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cidara cutting 30% of workforce to focus on CD388 for influenza
Cidara Therapeutics (NASDAQ:CDTX) said it was cutting around 30% of its workforce to focus resources on its drug-Fc conjugate candidate CD388 for the prevention of influenza A and B. The company added...
09-13 05:14
快讯 | Cidara Therapeutics 公司预计于2024年第三季度启动用于预防流感的 Cd388 第20亿临床试验。
Cidara Therapeutics Inc: Expects to Initiate Phase 2B Clinical Trial of Cd388 f...
09-13 04:21
快讯 | cidara therapeutics估计将在2024年第4季度主要发生大约120万美元的离职补偿和员工福利支出。
Cidara Therapeutics- Estimates Will Incur Charges of About $1.2 Mln for Severan...
09-13 04:20
快讯 | cidara therapeutics重组工作人员，专注于计划中的Cd388的临床发展。
Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Develop...
09-13 04:05
快讯 | Cidara Therapeutics公司计划削减员工人数，影响约30%的Cidara员工
Cidara Therapeutics Inc: Planned Reduction Impacts Approximately 30% of Cidara ...
09-13 04:05
快讯 | Cidara Therapeutics公司：继续就其肿瘤业务dfc计划进行商务拓展讨论
Cidara Therapeutics Inc: Continues Business Development Discussions for Its Onc...
09-13 04:05
快讯 | cidara therapeutics宣布任命Jim Beitel为首席业务官。
Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Offic...
08-20 05:12
快讯 | Cidara Therapeutics Inc: H.C. Wainwright升级至买入评级
Cidara Therapeutics Inc : H.c. Wainwright Raises to Buy Rating
08-14 18:38
Cidara Therapeutics GAAP EPS of -$20.65, revenue of $0.3M
Cidara Therapeutics press release (NASDAQ:CDTX): Q2 GAAP EPS of -$20.65. Revenue of $0.3M (-94.1% Y/Y). More on Cidara Therapeutics Cidara Therapeutics files for 16.8M common stock offering Seeking Al...
08-14 05:36
快讯 | Cidara Therapeutics Inc：本季度每股亏损$19.99
Cidara Therapeutics Inc: Qtrly Shr Loss $19.99
08-14 04:58
